US.IDXX · Idexx Laboratories

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.4094433427983866,
        "turnoverUsdM": 342.94269639639,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.IDXX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 555.1358,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 1,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.8,
      "take_profit_price": 636.9259,
      "target_multiplier": 1.9,
      "technical_strength": 1.6,
      "take_profit_percent": 6.9
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.818886685596773,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 75.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 66.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 9
  },
  "market": {
    "ma20": 565.6345,
    "ma50": 560.522,
    "close": 595.76,
    "prevClose": 586.67,
    "avgVolume20": 658832,
    "volumeRatio": 0.87,
    "changePercent": 1.55
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 9,
    "details": {
      "ret_5d": 0.049168742119149345,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 9,
      "vcp_bonus": 0,
      "vol_ratio": 0.8772377113510466,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 1.1851934424432855,
      "volat_points": 0,
      "day_range_pct": 0.03780048949576197,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 75.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 92,
        "contribution": 4.6
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.5,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 65,
        "contribution": 6.5
      },
      {
        "raw": 22,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 73.33,
        "contribution": 22
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 66.9,
    "details": [
      "基本面分析總分: 4.6/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 6.5/10分",
      "技術信號分析總分: 22/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 4.6,
      "資金流": 13.2,
      "市場環境": 8.6,
      "情緒分析": 6,
      "技術信號": 22,
      "風險管理": 6.5
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.75,
          "turnoverUsdM": 342.94269639639,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.IDXX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.9
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 700.7959967,
                "ma50": 714.2728007200001,
                "name": "QQQ",
                "close": 720.87,
                "points": 1.4
              },
              "spy": {
                "ma20": 751.3655031,
                "ma50": 747.5576037400001,
                "name": "SPY",
                "close": 773.030029,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.4094433427983866,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141137395,
                "url": "https://finnhub.io/api/news?id=508ecee4b431fd16e2434a6b8e6ab733a99c95454a2c88c6ea980ae36db4e0de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) could produce exceptional returns because of its solid growth attributes.",
                "category": "company",
                "datetime": 1786034702,
                "headline": "Here is Why Growth Investors Should Buy Idexx (IDXX) Now"
              },
              {
                "id": 141115049,
                "url": "https://finnhub.io/api/news?id=35666a9bb49c4defe08fd7f184a0fdaf5e5299135345edcdfa0af2ae31070cf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories Inc (IDXX) delivers 10% revenue growth and raises full-year EPS outlook, driven by innovation and international expansion despite soft US clinical visits.",
                "category": "company",
                "datetime": 1785877482,
                "headline": "IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ..."
              },
              {
                "id": 141111998,
                "url": "https://finnhub.io/api/news?id=83e1f9fb12f611558ef734564b6fd42e2870b2d019da6072c3946cd0eb8eb275",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories beats Q2 estimates, expands margins and raises its 2026 EPS outlook as diagnostics demand and adoption fuel growth.",
                "category": "company",
                "datetime": 1785858600,
                "headline": "IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-Market"
              },
              {
                "id": 141110272,
                "url": "https://finnhub.io/api/news?id=df4fe0d5649e29085ff8f5db2463bf2ba5929763aa3afc4e378245e55119c9f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785850203,
                "headline": "Idexx (IDXX) Reports Q2 Earnings: What Key Metrics Have to Say"
              },
              {
                "id": 141110757,
                "url": "https://finnhub.io/api/news?id=10d15d5066a10226b8b4f2707dca3e330f79462337105e2a790aa74f16daa661",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call August 4, 2026 8:30 AM EDTCompany ParticipantsAndrew Emerson - Executive VP, CFO &...",
                "category": "company",
                "datetime": 1785847203,
                "headline": "IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141108859,
                "url": "https://finnhub.io/api/news?id=e64abee23339868ce4d7fdeb84d6e5cab92de3c3011238b7cc317ca976d4a62e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) delivered earnings and revenue surprises of +8.10% and +1.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785843602,
                "headline": "Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141107590,
                "url": "https://finnhub.io/api/news?id=0635386d343671799513e1a251b0499c00d73d358e70668a88cd5cbd3cab1c9d",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "IDXX",
                "summary": "IDEXX Laboratories Q2 EPS beats estimates, revenue in line; raises full-year organic growth and margin outlook, shares rise 3.7% premarket.",
                "category": "company",
                "datetime": 1785843538,
                "headline": "IDEXX Laboratories (NASDAQ:IDXX) Shares Rise on Q2 Earnings Beat and Improved Outlook"
              },
              {
                "id": 141107199,
                "url": "https://finnhub.io/api/news?id=3fa4a1c8b8141c2ebb6d273173d2541b08b83b8dc8869f4c6e1e5382bd4bf23a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Evaluate the expected performance of Idexx (IDXX) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
                "category": "company",
                "datetime": 1785503704,
                "headline": "Insights Into Idexx (IDXX) Q2: Wall Street Projections for Key Metrics"
              }
            ],
            "raw_source": [
              {
                "id": 141157907,
                "url": "https://finnhub.io/api/news?id=a096396f458447a920bab41c4f6cb031f45ee83d78ac9b44c789b32bb0d1090b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2180557737/image_2180557737.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "IDEXX Labs remains a buy: durable moat, recurring revenue, raised FY26 EPS outlook, and long-term international growth. Click to see Q2 highlights & valuation.",
                "category": "company",
                "datetime": 1786176000,
                "headline": "IDEXX Laboratories: Worth The Premium"
              },
              {
                "id": 141137395,
                "url": "https://finnhub.io/api/news?id=508ecee4b431fd16e2434a6b8e6ab733a99c95454a2c88c6ea980ae36db4e0de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) could produce exceptional returns because of its solid growth attributes.",
                "category": "company",
                "datetime": 1786034702,
                "headline": "Here is Why Growth Investors Should Buy Idexx (IDXX) Now"
              },
              {
                "id": 141127989,
                "url": "https://finnhub.io/api/news?id=9ea47d2df35b0a3000496d548d8eb669c74f4e1765fc3d2d1d09adc207567acf",
                "image": "",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "UBS  analyst Andrea Alfonso   maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $620 to $670.",
                "category": "company",
                "datetime": 1785947269,
                "headline": "UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670"
              },
              {
                "id": 141127990,
                "url": "https://finnhub.io/api/news?id=2d8aeb3471d09af00fde5776b03b792f1a86254ca7c38f585d9ec65ec7c33492",
                "image": "",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "Citigroup  analyst Daniel Grosslight   maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $650 to $670.",
                "category": "company",
                "datetime": 1785941909,
                "headline": "Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670"
              },
              {
                "id": 141116574,
                "url": "https://finnhub.io/api/news?id=1609d532f3454898719b288eb650c0d0015b7435f5d672dd36fb565cb9b5e16b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Moby summary of IDEXX Laboratories, Inc.'s Q2 2026 earnings call",
                "category": "company",
                "datetime": 1785881732,
                "headline": "IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141115049,
                "url": "https://finnhub.io/api/news?id=35666a9bb49c4defe08fd7f184a0fdaf5e5299135345edcdfa0af2ae31070cf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories Inc (IDXX) delivers 10% revenue growth and raises full-year EPS outlook, driven by innovation and international expansion despite soft US clinical visits.",
                "category": "company",
                "datetime": 1785877482,
                "headline": "IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ..."
              },
              {
                "id": 141111997,
                "url": "https://finnhub.io/api/news?id=879ec92aa94d2ff93e91544e65d404a03f30dee6a7ec215f202c64407575e671",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter 2026 revenue growth of approximately 10% on a reported basis and 9% organically, driven by companion animal diagnostics, water and livestock, poultry and dairy businesses. The company raised its full-year revenue and earnings outlook, citing s",
                "category": "company",
                "datetime": 1785859468,
                "headline": "IDEXX Laboratories Q2 Earnings Call Highlights"
              },
              {
                "id": 141111998,
                "url": "https://finnhub.io/api/news?id=83e1f9fb12f611558ef734564b6fd42e2870b2d019da6072c3946cd0eb8eb275",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories beats Q2 estimates, expands margins and raises its 2026 EPS outlook as diagnostics demand and adoption fuel growth.",
                "category": "company",
                "datetime": 1785858600,
                "headline": "IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-Market"
              },
              {
                "id": 141110272,
                "url": "https://finnhub.io/api/news?id=df4fe0d5649e29085ff8f5db2463bf2ba5929763aa3afc4e378245e55119c9f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785850203,
                "headline": "Idexx (IDXX) Reports Q2 Earnings: What Key Metrics Have to Say"
              },
              {
                "id": 141108599,
                "url": "https://finnhub.io/api/news?id=9e1fcc0db18c7b217918b53e92794d7424423d9adeeac84c7117497a2224b4eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad",
                "category": "company",
                "datetime": 1785849279,
                "headline": "Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Strait of Hormuz Re-Opening Hopes"
              },
              {
                "id": 141110757,
                "url": "https://finnhub.io/api/news?id=10d15d5066a10226b8b4f2707dca3e330f79462337105e2a790aa74f16daa661",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call August 4, 2026 8:30 AM EDTCompany ParticipantsAndrew Emerson - Executive VP, CFO &...",
                "category": "company",
                "datetime": 1785847203,
                "headline": "IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141108584,
                "url": "https://finnhub.io/api/news?id=be360b5ab3037f6e5b84023ad5260321d5a02ff6bbf4cb5616b3d33c11e350aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "The 180 MW Phase II portion of the Millers Branch Solar Facility in Haskell County, Texas has achieved commercial operation. The capacity was contracted through Sustainability Roundtable, Inc's Net Zero Consortium for Buyers (NZCB) by Cisco, Juniper Networks (now part of Hewlett Packard Enterprise), Bio-Rad Laboratories, Cadence Design Systems, IDEXX Laboratories, Inc., PTC, and a large healthcare company, which signed an aggregated virtual power purchase agreement (VPPA) with Southern Power Com",
                "category": "company",
                "datetime": 1785846600,
                "headline": "SR Inc Net Zero Consortium for Buyers: Seven-Buyer Aggregation for 180 MW of Millers Branch Solar Now Online"
              },
              {
                "id": 141108858,
                "url": "https://finnhub.io/api/news?id=7bba2e26b45919de61a82ea0a88d1559c686252b35de4654cfef676d2bac86ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories Inc. (NASDAQ:IDXX) shares rose nearly 4% in pre-market trading after the veterinary diagnostics company reported second-quarter 2026 results that exceeded Wall Street expectations and increased its full-year earnings guidance.",
                "category": "company",
                "datetime": 1785845734,
                "headline": "IDEXX Laboratories Shares Climb After Earnings Beat and Improved Full-Year Outlook"
              },
              {
                "id": 141108859,
                "url": "https://finnhub.io/api/news?id=e64abee23339868ce4d7fdeb84d6e5cab92de3c3011238b7cc317ca976d4a62e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) delivered earnings and revenue surprises of +8.10% and +1.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785843602,
                "headline": "Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141110524,
                "url": "https://finnhub.io/api/news?id=d507772958f2a8a819a520e890396c431b45d6cadd3662cbe5fc9050696b43b5",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/04/Saint-Petersburg--Russia---June-25--2019.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (IDXX) stock rose after reporting Q2 earnings of $4.27/share and $1.22B in revenue, beating Wall Street estimates.",
                "category": "company",
                "datetime": 1785843581,
                "headline": "Why Is IDEXX Laboratories Stock Gaining Tuesday?"
              },
              {
                "id": 141107590,
                "url": "https://finnhub.io/api/news?id=0635386d343671799513e1a251b0499c00d73d358e70668a88cd5cbd3cab1c9d",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "IDXX",
                "summary": "IDEXX Laboratories Q2 EPS beats estimates, revenue in line; raises full-year organic growth and margin outlook, shares rise 3.7% premarket.",
                "category": "company",
                "datetime": 1785843538,
                "headline": "IDEXX Laboratories (NASDAQ:IDXX) Shares Rise on Q2 Earnings Beat and Improved Outlook"
              },
              {
                "id": 141107879,
                "url": "https://finnhub.io/api/news?id=ed480ae00c1539e1892006ea492210346c62f6b9a8e81f21bd2104a0bb3d9830",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "WESTBROOK, Maine, August 04, 2026--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results.",
                "category": "company",
                "datetime": 1785839400,
                "headline": "IDEXX Laboratories Announces Second Quarter Results"
              },
              {
                "id": 141110525,
                "url": "https://finnhub.io/api/news?id=ad9101e6b258fb9df0687c4fd5bfb4b57c4560459a911f54eec7154cb67c7bc3",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below.\nThis transcript is brought to you by",
                "category": "company",
                "datetime": 1785836133,
                "headline": "IDEXX Laboratories Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141110526,
                "url": "https://finnhub.io/api/news?id=1ad20007053f9b0a59617bdf1d05c449115862bcff863f1dc1744b563b72aed6",
                "image": "",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.45-$14.90 to $14.69-$14.94 vs $14.67 analyst estimate. Narrows FY2026 sales outlook from $4.675 billion-$4.760 billion to $4.700 billion-$4.745",
                "category": "company",
                "datetime": 1785825085,
                "headline": "IDEXX Laboratories Raises FY2026 GAAP EPS Guidance from $14.45-$14.90 to $14.69-$14.94 vs $14.67 Est; Narrows FY2026 Sales Guidance from $4.675B-$4.760B to $4.700B-$4.745B vs $4.711B Est"
              },
              {
                "id": 141110527,
                "url": "https://finnhub.io/api/news?id=62ef9305ab6ee3d802c53446aecac4ad338233beefe19782bf2a33317cea31b0",
                "image": "",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $4.27 per share which beat the analyst consensus estimate of $3.96 by 7.83 percent. This is a 17.63 percent increase over earnings of $3.63 per share from",
                "category": "company",
                "datetime": 1785825041,
                "headline": "IDEXX Laboratories Q2 EPS $4.27 Beats $3.96 Estimate, Sales $1.217B Beat $1.201B Estimate"
              },
              {
                "id": 141107199,
                "url": "https://finnhub.io/api/news?id=3fa4a1c8b8141c2ebb6d273173d2541b08b83b8dc8869f4c6e1e5382bd4bf23a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Evaluate the expected performance of Idexx (IDXX) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
                "category": "company",
                "datetime": 1785503704,
                "headline": "Insights Into Idexx (IDXX) Q2: Wall Street Projections for Key Metrics"
              },
              {
                "id": 141064002,
                "url": "https://finnhub.io/api/news?id=78a4d1603a77e856648e6b81ca7e57bd4535b29f68a48b51a09468d5d73cd6f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Corporate responsibility report puts IDEXX Laboratories (IDXX) in focus IDEXX Laboratories (IDXX) recently released its 2025 Corporate Responsibility Report, drawing attention to the stock as investors assess how the company’s plans for pet diagnostics, employees, and sustainability fit into its long term outlook. See our latest analysis for IDEXX Laboratories. The recent 6.3% 30 day share price return contrasts with IDEXX Laboratories’ share price being down 15.0% year to date, while the 3...",
                "category": "company",
                "datetime": 1785402557,
                "headline": "Is IDEXX Laboratories (IDXX) Fairly Valued After Its 2025 Corporate Responsibility Report?"
              },
              {
                "id": 141044045,
                "url": "https://finnhub.io/api/news?id=b1da3556d2d574e870a83df23713073e6a9208be636af8ce22b2f1ae4863e556",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (NASDAQ:IDXX) released its 2025 Corporate Responsibility Report, outlining progress across innovation, workforce development, and environmental initiatives that support the company’s long-term growth strategy. Key Investor TakeawaysIDEXX published its 2025 Corporate Responsibility Report, highlighting advances in innovation, employee development, and sustainability.",
                "category": "company",
                "datetime": 1785247577,
                "headline": "IDEXX Releases 2025 Corporate Responsibility Report Highlighting Innovation and Sustainability Progress"
              },
              {
                "id": 141041871,
                "url": "https://finnhub.io/api/news?id=b2b39e026a9f2b1d33a3361976ee4c82a3961bb0b961ec4983de41dc2a6ac5ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "WESTBROOK, Maine, July 28, 2026--IDEXX releases 2025 Corporate Responsibility Report highlighting progress against its goals and commitments.",
                "category": "company",
                "datetime": 1785236400,
                "headline": "IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals"
              },
              {
                "id": 141035335,
                "url": "https://finnhub.io/api/news?id=5955aa767bb5270fec33b69b0c4c5c70daa999824702bad4a7ec9365aa0a90a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Elanco Animal Health (ELAN) seems \"best-positioned name\" into the Q2 print, with IDEXX Laboratories",
                "category": "company",
                "datetime": 1785172169,
                "headline": "Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says"
              },
              {
                "id": 141037509,
                "url": "https://finnhub.io/api/news?id=24398a18d386daee23962fa28a40282f669fdac74cb88dc12bc606fba6db6311",
                "image": "",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "UBS  analyst Andrea Alfonso   maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers the price target from $640 to $620.",
                "category": "company",
                "datetime": 1785161332,
                "headline": "UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $620"
              },
              {
                "id": 141034163,
                "url": "https://finnhub.io/api/news?id=7dfbcbf4ac51d4c89fb1a320c9a619e05c9b4623934b10d1328c714f4f1f1c4e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDXX Laboratories heads into Q2 earnings with revenue and EPS growth expected, led by CAG diagnostics, VetLab gains and expanding software adoption.",
                "category": "company",
                "datetime": 1785157860,
                "headline": "Here's How IDEXX Laboratories Is Placed Ahead of Q2 Earnings"
              },
              {
                "id": 141032284,
                "url": "https://finnhub.io/api/news?id=7dd4d57acaf274b6e3e346093d3355cfad56eb8eb2422b863e70ef234edf607a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Jensen Investment Management, an asset management company based in the US, released its second-quarter 2026 investor letter for the “Jensen Quality Growth Equity Composite “. A copy of the letter is available to download here. The fund seeks long-term growth by investing in high-quality companies with durable competitive advantages. It returned 10.94% net of fees in […]",
                "category": "company",
                "datetime": 1785153600,
                "headline": "IDEXX Laboratories (IDXX) Looks Attractive on Recurring Revenue and High Customer Retention"
              },
              {
                "id": 140952943,
                "url": "https://finnhub.io/api/news?id=d9e8b333e8a462d43b0b84e3d28b24f605b4595d4a56df8c849f9112e8b797fe",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1056792912/image_1056792912.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IDXX",
                "summary": "Ron Baron’s BAMCO 13F update: $33.13B portfolio with Tesla top stake (13.39%), major buys/sells, and rebalancing moves—read more now.",
                "category": "company",
                "datetime": 1784468597,
                "headline": "Tracking Ron Baron's BAMCO Portfolio - Q1 2026 Update"
              },
              {
                "id": 140944614,
                "url": "https://finnhub.io/api/news?id=307e412a7579741a0fddefc62643bfcb67d4a3ac5c44974b5af6ec260e2e65c5",
                "image": "https://image.cnbcfm.com/api/v1/image/108335808-1784189865798-gettyimages-168597290-000023514379_Unapproved.jpeg?v=1784189915&w=1920&h=1080",
                "source": "CNBC",
                "related": "IDXX",
                "summary": "Startups are testing GLP-1 treatments for overweight cats while pet-food giants are leaning into longevity products as owners spend more on animal health.",
                "category": "company",
                "datetime": 1784336402,
                "headline": "Fat cat? Weight-loss drugs may be coming for your overweight pet"
              },
              {
                "id": 140912442,
                "url": "https://finnhub.io/api/news?id=d213a7bc45e61de090c471914ad23104be342b21d7fdfd1d103000c412ff81b2",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IDXX",
                "summary": "Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1784142301,
                "headline": "Which S&P500 stocks are moving on Wednesday?"
              },
              {
                "id": 140910529,
                "url": "https://finnhub.io/api/news?id=17e09f5f6e4cea4cc429b9c6762b4a6aea15f224d1fcabc885c31bb22bc18f3f",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IDXX",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1784133300,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 140909866,
                "url": "https://finnhub.io/api/news?id=1f4f929efb2a32e0b32eb27e903fc3db2f1bf483f90bbb2e518c77ea8ed7d823",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "As data centers strain water systems, FIW, PHO, and CGW offer investors ETF-based access to water utilities, infrastructure, and equipment firms, each with distinct fees and concentration.",
                "category": "company",
                "datetime": 1784040300,
                "headline": "These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending"
              },
              {
                "id": 140897029,
                "url": "https://finnhub.io/api/news?id=de059f2a8fa06678f5cc3ec3105d8f2309e7ab75251bb23b2ed80e39fd10c688",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.",
                "category": "company",
                "datetime": 1784029020,
                "headline": "Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H"
              },
              {
                "id": 140891433,
                "url": "https://finnhub.io/api/news?id=0d1b45131aa89d56944dfc353489756ba4f4b458a3280ab510525755ce221788",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories will release its second-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.",
                "category": "company",
                "datetime": 1783951251,
                "headline": "IDEXX Laboratories Earnings Preview: What to Expect"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 35,
            "discarded_article_count": 25
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.1,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.1,
            "vcp_reason": "波幅收縮(17.7%→12.8%)；站上MA50；升放量(近10日2日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 696800,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 750410,
              "avg_vol_20": 656195,
              "avg_vol_30": 696800,
              "range_pct_10": 0.12781995891265016,
              "range_pct_20": 0.15071510086754566,
              "range_pct_30": 0.17725263231414284,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0769374282433983,
              "dist_to_20d_high": 0.04548587533490758,
              "down_shrink_days": 2,
              "breakout_level_20d": 624.15002,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.7211174087734634
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.4094433427983866,
              "turnoverUsdM": 342.94269639639,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.IDXX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 555.1358,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 1,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.8,
            "take_profit_price": 636.9259,
            "target_multiplier": 1.9,
            "technical_strength": 1.6,
            "take_profit_percent": 6.9
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.818886685596773,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 20.3121,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.41
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 121.11
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1618
    },
    "kdj": {
      "d": 57.16,
      "j": 58.06,
      "k": 57.46,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 56.96
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 7322139,
      "recentSlope": 303093.9,
      "previousSlope": 65420
    },
    "rsi": 70.68,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 541.3306,
      "position": "SAR喺價下",
      "distancePct": 9.14,
      "previousTrend": "上升"
    },
    "ma50": 560.522,
    "macd": {
      "macd": 9.003563232238548,
      "trend": "強烈看漲",
      "signal": 5.293565773619779,
      "histogram": 3.709997458618769
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 569.9191,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 11
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.87,
      "score": 4,
      "avgVolume": 658832,
      "currentVolume": 575639
    },
    "derived": {
      "ma20": 565.6345,
      "ma50": 560.522,
      "prevClose": 586.67,
      "avgVolume10": 756714,
      "avgVolume20": 658832,
      "changePercent": 1.55,
      "avgVolumeForScore": 658832
    },
    "ma_cross": {
      "ma20": 565.6345,
      "ma50": 560.522,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 564.057,
      "prevMa50": 559.9674,
      "spreadPct": 0.91,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 532.2086,
      "upper": 599.0604,
      "position": "上半部"
    },
    "rsi_short": 86.71,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.87
    }
  }
}

{
  "close": 595.76,
  "volume": 575639,
  "changePercent": 1.55
}